Understanding breast cancer risk information
Part of Cancer, Skin clinical trials.
This study tests different ways of presenting breast cancer risk information and answers to common questions. It aims to help women make informed decisions about screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman
- You are between 39 and 74 years old
- You can read and understand English
- You have never had breast cancer or certain high-risk conditions
- You have not had chest radiation for Hodgkin's lymphoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different ways of teaching women about breast cancer and mammograms. It aims to see which method helps women feel more confident and more likely to get screened.
This study looks at how to decide the best breast cancer screening (like mammograms) based on your personal risk. It may help by testing a smarter way to match screening to your risk level.
This trial looks at a new way to tailor breast cancer screening using your personal risk and additional imaging. It may help find cancer earlier, especially for women at higher risk.
This study is testing a new way to use your genetic information (along with your family history) to better understand your personal risk for breast cancer. The goal is to see if giving this risk report to women with higher genetic risk can help them and their doctors make more informed decisions about screening and prevention.
This trial tests whether a planned education program can improve health beliefs and reduce fatalism in women who are at high risk for breast cancer. If you are 30 or older and have a high breast cancer risk score, this study may help you feel more in control of your health.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.